Browsing by Keyword : Carcinoma, Ovarian Epithelial
Showing results 8 to 18 of 18
Pub Year | | Title | Author(s) |
2023 | | Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant Chemotherapy | 장석준 |
2023 | | Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysis | 손주혁, 장석준 |
2023 | | Optimum selection criteria for secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer: A multicenter study from the Gynecologic Oncology Research Investigators coLLaborAtion group (GORILLA-3001) | 공태욱, 손주혁, 장석준 |
2018 | | Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement | 장석준 |
2020 | | Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer | 이진구 |
2020 | | Reduction of cycles of neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian or primary peritoneal cancer (ROCOCO): study protocol for a phase III randomized controlled trial | 장석준 |
2018 | | Risk factors for septic adverse events and their impact on survival in advanced ovarian cancer patients treated with neoadjuvant chemotherapy and interval debulking surgery | 공태욱, 백지흠, 손주혁, 유희석, 장석준 |
2023 | | Risk factors for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3004) | 공태욱, 김지연, 손주혁, 장석준 |
2023 | | Significance of cholecystectomy in cytoreductive surgery for advanced ovarian cancer | 공태욱, 김지연, 손주혁, 장석준 |
2024 | | Surgery for Recurrent Epithelial Ovarian Cancer | 장석준 |
2022 | | Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer: A Randomized Clinical Trial | 장석준 |
1